GLP-1 Receptor Agonists and NAION
GLP-1 receptor agonists likely increase NAION risk approximately twofold, but this rare event does not outweigh their cardiovascular and metabolic benefits for most patients.
Real-World Cardiovascular Outcomes of ObesityTreatment With Tirzepatide Versus Semaglutide
Tirzepatide significantly reduces new-onset heart failure risk compared to semaglutide in obese, non-diabetic adults over 12 months
Wall Street Zen Upgrades Cardiol Therapeutics to Hold – Sioux City Today
Wall Street Zen recently upgraded Cardiol Therapeutics to Hold, reflecting market confidence in cannabidiol cardiovascular therapeutics. This upgrade signals potential progress in cannabidiol cardiovascular clinical trials. Clinicians should monitor…
This Overlooked Hormone Could Explain Blood Pressure Challenges
Emerging research on blood pressure hormone regulation highlights a potential factor in persistent hypertension. This overlooked hormone may influence cardiovascular health and treatment outcomes. Understanding its role is crucial for advancing blood…
Study Finds Association Between Chronic Cannabis Use and Early Signs of Cardiovascular Dysfunction
This study highlights chronic cannabis cardiovascular risks linked to early markers of dysfunction. Clinicians should consider cardiovascular screening for chronic cannabis users. Understanding these risks aids patient safety and informed care.
Does Hitting Menopause Before 40 Cause Major Health Issues Later in Life?
Early menopause cardiovascular risk significantly affects women's long-term health outcomes. Premature menopause before age 40 increases risks of cardiovascular disease, bone loss, and neurological decline. Understanding these risks is essential for…
New Research Shows Cannabis Compounds May Boost Liver and Heart Health
Emerging cardiovascular and hepatic safety cannabis research suggests potential protective effects of cannabis compounds on liver and heart health. While promising, clinical evidence remains limited and requires further study. Patients should consult…
Specific Forms of Substance Misuse Increase Stroke Risk – Pulmonology Advisor
Stroke risk substance use varies depending on the specific substance involved. Different forms of substance misuse increase stroke risk through distinct mechanisms. Understanding these differences is crucial for accurate risk assessment and patient…
Specific Forms of Substance Misuse Increase Stroke Risk – Neurology Advisor
Stroke risk cannabis use patterns are increasingly studied for their clinical impact. Emerging evidence highlights the need for careful cardiovascular risk assessment. This article reviews key findings on cannabis and stroke risk.
Illicit Drug Use and Stroke: Cannabis Stroke Risk Assessment
Cannabis stroke risk assessment is crucial for clinicians evaluating patients with potential cerebrovascular issues. This focus keyword highlights the need for screening cannabis use during stroke risk evaluations. Understanding cannabis stroke risk…